• Home
  • About Us
  • Technology
  • Pipeline
  • Partnerships
  • News & Publications
HDT Bio

Frontiers in Medicine: sTREM-1 and TNF-α levels are associated with the clinical outcome of leprosy patients

Jun 29, 2023 | In the News

Click here to view...

Health Professional Radio: HDT Bio – Next Generation RNA Vaccine Platform

Jun 28, 2023 | In the News

Click here to view...

C&EN: Will cancer vaccines change the way we treat cancer?

Jun 25, 2023 | In the News

Click here to view...

BioTuesdays: HDT Bio focused on global impact of mRNA vaccine program

Jun 23, 2023 | In the News

Click here to view...

Bioprocess Online: Why therapeutic cancer vaccines—mRNA and otherwise—are having their day

May 24, 2023 | In the News

Click here to view...

Manufacturing The 3rd Biologics Revolution

May 23, 2023 | In the News

Click here to view...
« Older Entries
Next Entries »

Recent Posts

  • Providence Swedish Neuroscience Institute (PSNI) Reaches Milestone in Reducing Global Burden of Glioblastoma
  • A New Approach to Treating Brain Cancer: HDT Bio Launches Canadian Clinical Program at McGill University
  • KING5 Seattle Healthlink Feature: Seattle-based group testing new immunotherapy approach to treat deadly form of brain cancer
  • HDT Bio and UTMB Receive MCDC Innovation Prototype Award for Advancing CCHF Vaccine from Lab to Phase 1 Clinical Trial
  • FDA Greenlights HDT Bio’s First-in-Class HDT-321 for the Prevention of Deadly Tick-Borne Disease

Recent Comments

No comments to show.

Privacy Policy

Terms of Use

©2024 HDT Bio

  • Follow
  • Follow